Health & WellnessTech
Retina Technologies
An affordable, digital vision testing platform
New York,
NY
Investment type:
Equity
(Common)
Target raise:
$9,999
- $1,070,000
Minimum investment:
$234
$234
End date:
Apr 30, 2022
Apr 30, 2022
ended
Our Story
Retina Technologies is a medical device company that is defining the future of vision care. We developed the OcuVue digital vision screening platform to help eliminate treatable vision loss and blindness by enabling early detection and prevention. OcuVue is a modular headset that harnesses the power of virtual reality, retinal imaging, and machine learning to deliver affordable and comprehensive vision examinations that can be easily performed by any healthcare professional anywhere. RetTech focuses on providing affordable, accessible vision screening to the global community by harnessing the power of modularity. The company was founded by a group of medical school students who realized that current vision testing practices are inefficient and costly. RetTech seeks to modernize vision screening by drastically improving ease-of-use, affordability, and accessibility through streamlined integration in any healthcare practice. The Company is currently at the pre-revenue, prototype development stage of our modular ophthalmic digital vision testing and screening solution, OcuVue.